miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A

BACKGROUND: Development of resistance to inhibitors of BRAF (BRAFi) and MEK (MEKi) remains a great challenge for targeted therapy in patients with BRAF-mutant melanoma. Here, we explored the role of miRNAs in melanoma acquired resistance to BRAFi. METHODS: miRNA expression in two BRAF-mutant melanom...

Descripción completa

Detalles Bibliográficos
Autores principales: Caporali, Simona, Amaro, Adriana, Levati, Lauretta, Alvino, Ester, Lacal, Pedro Miguel, Mastroeni, Simona, Ruffini, Federica, Bonmassar, Laura, Antonini Cappellini, Gian Carlo, Felli, Nadia, Carè, Alessandra, Pfeffer, Ulrich, D’Atri, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588909/
https://www.ncbi.nlm.nih.gov/pubmed/31227006
http://dx.doi.org/10.1186/s13046-019-1238-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588909/
https://www.ncbi.nlm.nih.gov/pubmed/31227006
http://dx.doi.org/10.1186/s13046-019-1238-4

Ejemplares similares